FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046201426> ?p ?o ?g. }

• W2046201426 endingPage "613" @default.
• W2046201426 startingPage "605" @default.
• W2046201426 abstract "Intermedin (IMD), also called adrenomedullin-2, is a peptide that belongs to the calcitonin/calcitonin gene-related peptide/amylin peptide family. IMD exerts many effects on the cardiovascular system, gastrointestinal tract, and central nervous system. Here, we analyzed the expression of the IMD peptide in human skin of healthy controls, in biopsies from lesional and non-lesional areas of atopic dermatitis (AD) skin, in cultured human keratinocytes, and in the HaCaT keratinocyte cell line at the transcriptional (quantitative reverse transcription-PCR) and translational (immunohistochemistry) level. IMD messenger RNA (mRNA) and protein could be detected in keratinocytes and human skin. Keratinocytes, nerve fibers, periglandular cells, arterial/arteriolar smooth muscle cells, and pericytes of dermal microvessels were intensely IMD-immunoreactive. The IMD mRNA was, compared to healthy skin, significantly reduced in lesional and non-lesional areas of AD skin. This was accompanied by a reduction of IMD immunoreactivity in pericytes of the upper dermis indicating that skin from AD patients is generally affected, and downregulation of IMD in AD skin is not a secondary phenomenon caused by acute inflammation but is a general characteristic of AD skin. These data further point to a role of IMD expressed by pericytes in conferring higher susceptibility of the skin of AD patients to inflammatory stimuli. Intermedin (IMD), also called adrenomedullin-2, is a peptide that belongs to the calcitonin/calcitonin gene-related peptide/amylin peptide family. IMD exerts many effects on the cardiovascular system, gastrointestinal tract, and central nervous system. Here, we analyzed the expression of the IMD peptide in human skin of healthy controls, in biopsies from lesional and non-lesional areas of atopic dermatitis (AD) skin, in cultured human keratinocytes, and in the HaCaT keratinocyte cell line at the transcriptional (quantitative reverse transcription-PCR) and translational (immunohistochemistry) level. IMD messenger RNA (mRNA) and protein could be detected in keratinocytes and human skin. Keratinocytes, nerve fibers, periglandular cells, arterial/arteriolar smooth muscle cells, and pericytes of dermal microvessels were intensely IMD-immunoreactive. The IMD mRNA was, compared to healthy skin, significantly reduced in lesional and non-lesional areas of AD skin. This was accompanied by a reduction of IMD immunoreactivity in pericytes of the upper dermis indicating that skin from AD patients is generally affected, and downregulation of IMD in AD skin is not a secondary phenomenon caused by acute inflammation but is a general characteristic of AD skin. These data further point to a role of IMD expressed by pericytes in conferring higher susceptibility of the skin of AD patients to inflammatory stimuli. atopic dermatitis adrenomedullin alpha-smooth muscle actin calcitonin gene-related peptide calcitonin receptor-like receptor threshold cycle intermedin messenger RNA receptor activity-modifying protein reverse transcription" @default.
• W2046201426 created "2016-06-24" @default.
• W2046201426 creator A5004001005 @default.
• W2046201426 creator A5004992841 @default.
• W2046201426 creator A5019351872 @default.
• W2046201426 creator A5032824470 @default.
• W2046201426 creator A5035971257 @default.
• W2046201426 creator A5036622041 @default.
• W2046201426 creator A5037658208 @default.
• W2046201426 creator A5038514497 @default.
• W2046201426 creator A5042806677 @default.
• W2046201426 creator A5074555411 @default.
• W2046201426 date "2007-03-01" @default.
• W2046201426 modified "2023-10-15" @default.
• W2046201426 title "Intermedin: A Skin Peptide that Is Downregulated in Atopic Dermatitis" @default.
• W2046201426 cites W1549859258 @default.
• W2046201426 cites W1583258274 @default.
• W2046201426 cites W1963828774 @default.
• W2046201426 cites W1966448358 @default.
• W2046201426 cites W1980298938 @default.
• W2046201426 cites W1983031501 @default.
• W2046201426 cites W1988008838 @default.
• W2046201426 cites W1988581402 @default.
• W2046201426 cites W1989419353 @default.
• W2046201426 cites W1991733456 @default.
• W2046201426 cites W1992031673 @default.
• W2046201426 cites W1992190771 @default.
• W2046201426 cites W1999112366 @default.
• W2046201426 cites W2001368948 @default.
• W2046201426 cites W2005756070 @default.
• W2046201426 cites W2006642837 @default.
• W2046201426 cites W2009206983 @default.
• W2046201426 cites W2009902430 @default.
• W2046201426 cites W2011648537 @default.
• W2046201426 cites W2018106895 @default.
• W2046201426 cites W2019881647 @default.
• W2046201426 cites W2026230128 @default.
• W2046201426 cites W2026658988 @default.
• W2046201426 cites W2031603956 @default.
• W2046201426 cites W2031895676 @default.
• W2046201426 cites W2032513172 @default.
• W2046201426 cites W2043008229 @default.
• W2046201426 cites W2044285853 @default.
• W2046201426 cites W2054064669 @default.
• W2046201426 cites W2059110040 @default.
• W2046201426 cites W205982582 @default.
• W2046201426 cites W2064022604 @default.
• W2046201426 cites W2065096154 @default.
• W2046201426 cites W2066199828 @default.
• W2046201426 cites W2067758011 @default.
• W2046201426 cites W2075900728 @default.
• W2046201426 cites W2076680406 @default.
• W2046201426 cites W2086079082 @default.
• W2046201426 cites W2086311210 @default.
• W2046201426 cites W2088168673 @default.
• W2046201426 cites W2094899441 @default.
• W2046201426 cites W2114496307 @default.
• W2046201426 cites W2131393213 @default.
• W2046201426 cites W2140088428 @default.
• W2046201426 cites W2143138262 @default.
• W2046201426 cites W2143464311 @default.
• W2046201426 cites W2150732805 @default.
• W2046201426 cites W2151430185 @default.
• W2046201426 cites W2153249226 @default.
• W2046201426 cites W268165686 @default.
• W2046201426 doi "https://doi.org/10.1038/sj.jid.5700576" @default.
• W2046201426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17008878" @default.
• W2046201426 hasPublicationYear "2007" @default.
• W2046201426 type Work @default.
• W2046201426 sameAs 2046201426 @default.
• W2046201426 citedByCount "9" @default.
• W2046201426 countsByYear W20462014262012 @default.
• W2046201426 countsByYear W20462014262016 @default.
• W2046201426 countsByYear W20462014262017 @default.
• W2046201426 crossrefType "journal-article" @default.
• W2046201426 hasAuthorship W2046201426A5004001005 @default.
• W2046201426 hasAuthorship W2046201426A5004992841 @default.
• W2046201426 hasAuthorship W2046201426A5019351872 @default.
• W2046201426 hasAuthorship W2046201426A5032824470 @default.
• W2046201426 hasAuthorship W2046201426A5035971257 @default.
• W2046201426 hasAuthorship W2046201426A5036622041 @default.
• W2046201426 hasAuthorship W2046201426A5037658208 @default.
• W2046201426 hasAuthorship W2046201426A5038514497 @default.
• W2046201426 hasAuthorship W2046201426A5042806677 @default.
• W2046201426 hasAuthorship W2046201426A5074555411 @default.
• W2046201426 hasBestOaLocation W20462014261 @default.
• W2046201426 hasConcept C104317684 @default.
• W2046201426 hasConcept C105580179 @default.
• W2046201426 hasConcept C118303440 @default.
• W2046201426 hasConcept C118995209 @default.
• W2046201426 hasConcept C126322002 @default.
• W2046201426 hasConcept C134018914 @default.
• W2046201426 hasConcept C142724271 @default.
• W2046201426 hasConcept C163170386 @default.
• W2046201426 hasConcept C165220095 @default.
• W2046201426 hasConcept C170493617 @default.
• W2046201426 hasConcept C2777152744 @default.
• W2046201426 hasConcept C2777459323 @default.

• next